Jin Medical International: A New Chapter in Rehabilitation Equipment Manufacturing
CHANGZHOU, China, Jan. 22, 2026 /PRNewswire/ — Jin Medical International Ltd. (NASDAQ: ZJYL) has jubilantly announced the substantial progress made by its wholly-owned subsidiary, Zhongjin Medical Equipment Co., Ltd., in constructing a new manufacturing facility in Chuzhou, Anhui Province. This facility is set to commence full capacity production by the end of April 2026, a development aimed at bolstering Jin Medical’s production capabilities.
The regulatory completion for the Chuzhou facility was achieved on December 29, 2025, marking a pivotal milestone with the successful acquisition of a license for Class I Medical Device production. This certification positions the company to meet rising demands in the rehabilitation medical equipment sector, particularly in the production of mid-to-high-end electric wheelchairs and senior mobility scooters.
Strategic Location and Operational Efficiency
The choice of Chuzhou for this new facility is not coincidental; it lies within the Yangtze River Delta’s manufacturing hub, an area renowned for its strategic advantages in logistics and supply chain management. The facility’s projected output of 200,000 units annually is expected to significantly enhance Jin Medical’s manufacturing capacity for premium mobility products. This strategic location promises not just operational efficiency but also facilitates a quicker response to market demands—be they domestic or international.
Dr. Erqi Wang, the Chairman and CEO of Jin Medical, emphasized the importance of this project in the company’s overarching strategy. According to him, the Chuzhou base will not only bolster the resilience of their supply chain but also optimize global production capacities. With an emphasis on utilizing automated production lines, the facility aims to enhance cost control and product quality consistency right from the start.
Market Context: Addressing the Global Aging Trend
Jin Medical’s expansion comes at a time when the global demand for assistive devices is on the rise, driven by an aging population worldwide. It highlights the company’s commitment to not only serving the local market but also positioning itself as a competitive player in the international arena. With the Chuzhou facility fully operational, Jin Medical anticipates improvements in its market competitiveness through effective scaled production.
About Jin Medical International Ltd.
Founded in 2006 and headquartered in Changzhou, Jiangsu Province, Jin Medical is a prominent player in the design, development, manufacture, and marketing of rehabilitation products. With two existing manufacturing plants totaling approximately 230,000 square feet in Changzhou and Taizhou, the company is now expanding its footprint with an additional 430,000 square feet facility in Chuzhou. Operating over 40 distribution partnerships domestically and more than 20 internationally, Jin Medical is poised to harness its expansive network to meet the needs of its customers effectively.
The company’s product line includes more than 30 models of wheelchairs, predominantly catering to the Japanese and Chinese markets. As a manufacturer committed to innovation, Jin Medical focuses on delivering lightweight, ergonomic products optimized for user comfort and mobility. For more information about their offerings, you can visit www.zhjmedical.com.
Forward-Looking Statements: Navigating Risks and Opportunities
This announcement includes forward-looking statements, as defined by the Private Securities Litigation Reform Act of 1995. Statements that express plans, objectives, or future performance involve risks and uncertainties that may cause actual results to differ from expectations. Factors such as competitive market dynamics, government regulations, and technological changes can all influence performance outcomes.
Investors are advised to remain aware of these risks and not place undue reliance on any forward-looking statements made in this announcement. Comprehensive details regarding the company’s performance and risks can be found in its filings with the U.S. Securities and Exchange Commission (SEC)—accessible at www.sec.gov.
For more information, please contact:
View original content: https://www.prnewswire.com/news-releases/jin-medical-announces-the-official-commencement-date-of-chuzhou-facility-302667965.html
SOURCE Jin Medical International Ltd.
